Key Releases are ad hoc announcements pursuant to SIX Swiss Exchange Article 53 Listing Rules.
Header
News archive
News Archive Navigation
icon
News Archive Navigation Language
Language Preferences
Showing 44 results
September 2020
April 2020
-
StatementNovartis announces plan to initiate clinical trial of canakinumab for patients with COVID-19 pneumonia
-
StatementNovartis announces flexible return to office and on-site field activities, starting May 11, 2020
-
StatementNovartis joins the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) initiative
-
StatementNovartis completes safety review and initiates update to the Beovu® prescribing information worldwide
-
StatementNovartis announces first European donation of hydroxychloroquine to Switzerland